187 related articles for article (PubMed ID: 15838236)
1. Emerging biologic therapies in rheumatoid arthritis: cell targets and cytokines.
Singh R; Robinson DB; El-Gabalawy HS
Curr Opin Rheumatol; 2005 May; 17(3):274-9. PubMed ID: 15838236
[TBL] [Abstract][Full Text] [Related]
2. Rheumatoid arthritis: non-tumor necrosis factor targets.
Pollard L; Choy E
Curr Opin Rheumatol; 2005 May; 17(3):242-6. PubMed ID: 15838231
[TBL] [Abstract][Full Text] [Related]
3. Biologic therapy for rheumatoid arthritis: clinical efficacy and predictors of response.
Gibbons LJ; Hyrich KL
BioDrugs; 2009; 23(2):111-24. PubMed ID: 19489652
[TBL] [Abstract][Full Text] [Related]
4. Co-stimulatory blockade as therapy for rheumatoid arthritis.
Mackie SL; Vital EM; Ponchel F; Emery P
Curr Rheumatol Rep; 2005 Oct; 7(5):400-6. PubMed ID: 16174492
[TBL] [Abstract][Full Text] [Related]
5. [Biopharmaceuticals in the treatment of rheumatoid arthritis].
Baslund B; Bendtzen K
Ugeskr Laeger; 2008 Jun; 170(24):2108-10. PubMed ID: 18572481
[TBL] [Abstract][Full Text] [Related]
6. New therapies for rheumatoid arthritis.
Goldblatt F; Isenberg DA
Clin Exp Immunol; 2005 May; 140(2):195-204. PubMed ID: 15807842
[TBL] [Abstract][Full Text] [Related]
7. Treatment of rheumatoid arthritis: new therapeutic approaches with biological agents.
Afeltra A
Curr Drug Targets Immune Endocr Metabol Disord; 2001 May; 1(1):45-65. PubMed ID: 12476781
[TBL] [Abstract][Full Text] [Related]
8. Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial.
Wijesinghe H; Galappatthy P; de Silva R; Seneviratne SL; Saravanamuttu U; Udagama P; Hart M; Kelleher P; Senerath U; Fernandopulle R; Weerasekera LP; Wijayaratne LS
BMC Musculoskelet Disord; 2017 Jul; 18(1):310. PubMed ID: 28724365
[TBL] [Abstract][Full Text] [Related]
9. [New drugs and treatment strategies for rheumatoid arthritis].
Fantini F
Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798
[TBL] [Abstract][Full Text] [Related]
10. [Indications and efficacy of biologics in inflammatory arthritis].
Combe B
Bull Acad Natl Med; 2012 Oct; 196(7):1279-92; discussion 1293. PubMed ID: 23815014
[TBL] [Abstract][Full Text] [Related]
11. Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection.
Biggioggero M; Crotti C; Becciolini A; Favalli EG
Drug Des Devel Ther; 2019; 13():57-70. PubMed ID: 30587928
[TBL] [Abstract][Full Text] [Related]
12. Biologic therapy for early rheumatoid arthritis: the latest evidence.
Castro-Rueda H; Kavanaugh A
Curr Opin Rheumatol; 2008 May; 20(3):314-9. PubMed ID: 18388524
[TBL] [Abstract][Full Text] [Related]
13. CTLA-4 blockade in the treatment of rheumatoid arthritis: an update.
Cutolo M; Sulli A; Paolino S; Pizzorni C
Expert Rev Clin Immunol; 2016; 12(4):417-25. PubMed ID: 26679631
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 in rheumatoid arthritis.
Nishimoto N
Curr Opin Rheumatol; 2006 May; 18(3):277-81. PubMed ID: 16582692
[TBL] [Abstract][Full Text] [Related]
15. When is switching warranted among biologic therapies in rheumatoid arthritis?
Reynolds A; Koenig AS; Bananis E; Singh A
Expert Rev Pharmacoecon Outcomes Res; 2012 Jun; 12(3):319-33. PubMed ID: 22812556
[TBL] [Abstract][Full Text] [Related]
16. [Rituximab in patients with rheumatoid arthritis: systematic review].
Brodszky V; Czirják L; Géher P; Hodinka L; Kárpáti K; Péntek M; Poór G; Szekanecz Z; Gulácsi L
Orv Hetil; 2007 Oct; 148(40):1883-93. PubMed ID: 17905683
[TBL] [Abstract][Full Text] [Related]
17. What is the place of recently approved T cell-targeted and B cell-targeted therapies in the treatment of rheumatoid arthritis? Lessons from global clinical trials.
Smolen JS
J Rheumatol Suppl; 2007 Jul; 79():15-20. PubMed ID: 17611974
[TBL] [Abstract][Full Text] [Related]
18. Evidence that cytokines play a role in rheumatoid arthritis.
Brennan FM; McInnes IB
J Clin Invest; 2008 Nov; 118(11):3537-45. PubMed ID: 18982160
[TBL] [Abstract][Full Text] [Related]
19. Clinical trials on biologics in rheumatoid arthritis.
Sander O; Rau R
Int J Clin Pharmacol Ther; 1998 Nov; 36(11):621-4. PubMed ID: 9849754
[TBL] [Abstract][Full Text] [Related]
20. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
Goldblatt F; Isenberg DA
Handb Exp Pharmacol; 2008; (181):163-81. PubMed ID: 18071946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]